- Delhi HC attaches Ranbaxy promoters' assets to enforce Daiichi award 26 February 2018
- Daiichi case: thwarted in SC, Singhs may return to Singapore courts 17 February 2018
- Ranbaxy's Singh bros must pay Daiichi Rs3,500 cr, rules HC 01 February 2018
- Sun Pharma sells two Ranbaxy units to Strides Arcolab 21 September 2015
- Sun, Ranbaxy complete $4-bn merger 24 March 2015
- Sun-Ranbaxy merger deal nears closure with HC nod 09 March 2015
- Sun Pharma buyout of Ranbaxy gets conditional US nod 31 January 2015
- Sun Pharma, Ranbaxy merger deal gets conditional CCI nod 09 December 2014
- After US, Germany bans Ranbaxy antibiotic from Dewas plant 04 December 2014
- US court dumps Ranbaxy's bid to stall launch of rival generics 20 November 2014
- Ranbaxy sues US FDA over revoking drug approvals 18 November 2014
- Ranbaxy made to pay $40mn to settle pricing litigation in US 16 October 2014
- Ranbaxy grilled by US Justice Dept over Medicaid drug pricing 18 September 2014
- US judge upholds Ranbaxy-Pfizer Lipitor marketing deal 13 September 2014
- Sun Pharma hopes to turn around Ranbaxy in four years of closing deal 12 September 2014
- Competition panel seeks public comments on Sun-Ranbaxy merger deal 04 September 2014
- CCI worried about 'molecular' effect of Sun-Ranbaxy merger 30 August 2014
- Sun-Ranbaxy merger: competition panel demands more details 28 August 2014
- EU lifts ban on Ranbaxy's Toansa-made drugs 06 June 2014
- SC blasts manner of stalling Sun-Ranbaxy merger 21 May 2014
- Ranbaxy drug flows to Europe, US to dry up 09 April 2014
- Sun Pharma, Ranbaxy to merge in Rs24,000 all-stock deal 07 April 2014
- Ranbaxy suspends all shipments from Toansa, Dewas plants 25 February 2014
- Ranbaxy, Teva to pay $15,000 each to settle US anti-trust case 20 February 2014
- FDA ban will only impact US business 10-15%: Ranbaxy 06 February 2014
- After FDA, Ranbaxy under scanner of Indian authorities too 30 January 2014
- Ranbaxy hit afresh by FDA; all its India-made products banned 24 January 2014
- US FDA raises concerns over a fourth Ranbaxy facility 14 January 2014
- Ranbaxy to invest $40 million to set up a second plant in Malaysia 13 September 2012
- Ranbaxy in licensing pact with Gilead for HIV drug 03 August 2012
- Daiichi Sankyo to market Ranbaxy drugs in Venezuela 20 June 2012
- Ranbaxy begins US exports of generic Lipitor from Mohali 02 April 2012
- Ranbaxy opens new manufacturing facility in Morocco 12 March 2012
- Ranbaxy may hand over Latin American marketing to Daiichi Sankyo 25 February 2012
- Ranbaxy reports Rs2,983 crore Q4 loss on US probe provisioning 23 February 2012
- Ranbaxy to pay $500 million to settle USFDA ban 21 December 2011
- Ranbaxy to share Lipitor profits with Teva 02 December 2011
- US FDA lifts curbs on Ranbaxy's generic Lipitor sales 01 December 2011
- No immediate gain for Ranbaxy despite Lipitor patent's expiry 30 November 2011
- Pfizer, Ranbaxy sued over Lipitor price fixing in the US 10 November 2011
- Ranbaxy Labs reports Rs465-crore net loss for July-September quarter 09 November 2011
- Ranbaxy to launch generic 'Lipitor' in US by November 09 September 2011
- Ranbaxy's subsidiary launches esomeprazole in UK 05 September 2011
- Ranbaxy April-June net down over 25 per cent at Rs243 crore 05 August 2011
- Ranbaxy in settlement talks with USFDA: Reports 05 May 2011
- Mylan Inc sues USFDA to block Ranbaxy's Lipitor bid 21 March 2011
- Ranbaxy, Russian region sign MoU on healthcare cooperation 31 January 2011
- Merck and Ranbaxy end drug development pact 06 January 2011
- Ranbaxy registers 168 per cent leap in end-Sept profit 12 November 2010
- Ranbaxy recalls nerve pain drug from UK market 04 June 2010
- Ranbaxy boosts Daiichi Sankyo's Q1 profits 13 May 2010
- Ranbaxy recalls two consignments of drugs from US market 15 April 2010
- Ranbaxy, Dow arm tie up to develop biosimilar protein 29 March 2010
- US FDA rejects Ranbaxy's application for generic Flomax 03 March 2010
- Ranbaxy swings back to profit 25 February 2010
- US FDA asks Ranbaxy to ensure plant standards compliance: report 05 February 2010
- Ranbaxy acquires Biovel to enter vaccines business 19 January 2010
- Ranbaxy sells Chinese JV stake to state-owned firm 29 December 2009
- Ranbaxy again feels FDA heat – this time over US plant 26 December 2009
- Ranbaxy to launch anti-hypertensive drug in six African countries 21 December 2009
- Ranbaxy exits JV with Japan's Nippon Chemiphar 09 December 2009
- Ranbaxy launches generic herpes drug in US 27 November 2009
- Ranbaxy posts Rs186.08 crore in Q2 profits 27 October 2009
- EU official raid Ranbaxy French unit 08 October 2009
- Ranbaxy to market Daiichi Sankyo products in Mexico 05 October 2009
- Ranbaxy in-licenses cosmetic product Neuronox from Medy-Tox, South Korea 17 September 2009
- Ranbaxy launches authorised generic version of Validus's Rocaltrol 03 September 2009
- Ranbaxy's peptic ulcer drug cleared for US launch 25 August 2009
- Religare bids for ING's Asian assets 17 August 2009
- Markets cheer Malvinder's exit from Ranbaxy 26 May 2009
- Religare in race for AIG's fund management unit 12 May 2009
- Ranbaxy to launch Daiichi's hypertension drug in India 31 March 2009
- UK, Australia okay drugs from Ranbaxy plant 24 March 2009
- Ranbaxy's cardio drug `Ramipril' gets US FDA approval 09 March 2009
- Ranbaxy hospital group Fortis taps outdoor opportunities 03 March 2009
- Ranbaxy plant in India falsified data: US FDA 25 February 2009
- Bhavdeep Singh becomes CEO of Fortis 24 February 2009
- FDA woes hit Ranbaxy in Q4 23 January 2009
- Ranbaxy in pact to market BioPro's brain tumour drug in India 03 December 2008
- Daiichi Sankyo completes Ranbaxy acquisition 07 November 2008
- Daiichi acquires 52.5 per cent in Ranbaxy 20 October 2008
- Ranbaxy-Daiichi deal hits a regulatory bump 17 October 2008
- Ranbaxy hires New York ex-mayor Giuliani to resolve issues with US FDA 18 September 2008
- US FDA bans import of over 30 Ranbaxy generic drugs 17 September 2008
- Cabinet likely to clear Daiichi-Ranbaxy deal next month 26 August 2008
- Daiichi awaits SEBI nod for launching open offer for Ranbaxy 02 August 2008
- UK Crown court rejects charges against Ranbaxy 23 July 2008
- MNC rival trying to scuttle Daiichi deal: Ranbaxy 18 July 2008
- AEGON Religare Life Insurance gets IRDA approval 30 June 2008
- Daiichi to make open offer for Ranbaxy on August 8 16 June 2008
- Ranbaxy to develop new drugs for Merck & Co 10 May 2008
- Ranbaxy to introduce dental drug Inersan in India, Nepal 18 March 2008
- Ranbaxy launches Osonase nasal spray in India 25 October 2007
- Ranbaxy follows Sun Pharma in demerging R&D business 19 October 2007
- Ranbaxy to raise stake in Zenotech Laboratories 13 October 2007
- Ranbaxy to up Zenotech Lab stake to 45 per cent for Rs214 crore 03 October 2007
- Ranbaxy receives WHO pre-qualification for three more ARVS 15 September 2007
- Ipca-Ranbaxy alliance to market Metformin HCL tablets in US 14 August 2007
- US FDA approves Ranbaxy''s pravastatin sodium tablets 25 April 2007
- Ranbaxy-GSK alliance to develop respiratory drug 02 April 2007
- Ranbaxy launches asthma drug 'Osovair' in India 30 March 2007
- Ranbaxy-Glaxo extend pact 07 February 2007
- Glaxo moves court against Ranbaxy''s generic drug 03 February 2007
- Ranbaxy launches two NDDS Urology products in India 30 January 2007
- Ranbaxy wins Lipitor patent against Pfizer in Australia 21 December 2006
- Ranbaxy gets USFDA approval for Cefprozil anti-infective tablets 15 December 2006
- US Court''s Zocor verdict to benefit Ranbaxy and Dr Reddy''s 15 November 2006
- Ranbaxy to introduce Debiopharm's gastro drug in India 23 October 2006
- US FDA approves Ranbaxy's sale of furosemide in the US 21 September 2006
- Ranbaxy to market Ethypharm's cardiovascular drug in India 18 September 2006
- Ranbaxy wins two additional atorvastatin patents in Norway 30 August 2006
- Mixed victory for Ranbaxy in patent row with Pfizer 03 August 2006
- Ranbaxy's 'Cefprozil' gets US FDA approval 01 July 2006
- Ranbaxy acquires Romanian drug firm for $324 million 29 March 2006
- Dr Reddy's beats Ranbaxy; snaps up Betapharm for €480 million 16 February 2006
- Ranbaxy raises $400 million from FCCB issue 16 February 2006
- Dr Reddy's, Ranbaxy lead race to acquire 3i's stake in Betapharm 03 February 2006
- Ranbaxy in co-marketing agreement with Ferring of Switzerland 10 January 2006
- Ranbaxy, Cephalon to settle Provigil patent litigation 22 December 2005
- Ranbaxy offers to help U S combat avian flu 02 December 2005
- Ranbaxy honours scientists for outstanding research 28 November 2005
- US Court of Appeals upholds preliminary injunction against Ranbaxy 23 November 2005
- AstraZeneca sues Ranbaxy on Nexium patent 22 November 2005
- Ranbaxy scores over Pfizer in Norwegian court over cholesterol drug 10 November 2005
- Ranbaxy obtains US FDA approval for high BP drug 14 September 2005
- Maharashtra FDA questions claims of nutraceuticals 28 June 2005
- USFDA gives tentative nod for Ranbaxy drug 01 June 2005
- Ranbaxy makes three fresh ARV filings to WHO 25 January 2005
- Ranbaxy Top brass reshuffled 22 January 2005
- Ranbaxy Q4 results disappoints 19 January 2005
- Ranbaxy withdraws its antiretroviral''s from WHO list 10 November 2004
- Ranbaxy net down six per cent 02 August 2004
- Ranbaxy in pact for new drug discovery 30 April 2004
- Ranbaxy crosses the billion dollar mark 11 March 2004
- Ranbaxy enters the field of herbal medicine 22 January 2004
- USFDA approval for Ranbaxy drug 10 January 2004
- WHO declares pre-qualification of Ranbaxy''s Triviro-LNS tablets 04 December 2003
- Ranbaxy to invest Rs 120 crore for R&D in Andhra Pradesh 22 September 2003
- Ranbaxy to provide AIDS drugs to 10 lakh patients 29 November 2002
- Ranbaxy Laboratories clocks Rs 1,594-million Q2 net profit 18 October 2002
- Ranbaxy secures 10% stake in Nihon Pharma 26 September 2002
- Ranbaxy gets USFDA approval for Terazosin 26 September 2002
- Ranbaxy refutes Glaxo’s charge of stealing 24 August 2002
- Glaxo SmithKline to sue Novartis, Ranbaxy 23 August 2002
- Ranbaxy acquires Signature Pharma facility 23 July 2002
- Ranbaxys new chemical entity gets license 27 June 2002
- Ranbaxy Labs wants to buy out SRL 14 February 2002
- Ranbaxy joins hands with NIPER 10 January 2002
- Pharma sector fared well in 2001 28 December 2001
- Sildenafil citrate drug sales surge 05 December 2001
- The future is bright for pharma firms 21 November 2001
- Ranbaxy Fine Chemicals Ltd 01 March 2000
- Ranbaxy to sell ranitidine 75mg tablets in the US 13 January 2000
- Ranbaxy closes $65 million Bayer deal 09 September 1999
- Ranbaxy to raise research spending to 6 per cent of sales by 2002 09 September 1999
- Hoechst, Nicholas Piramal to co-market two products 01 July 1999
- Ranbaxy pushes Pravosin to phase-1 trials 30 May 1999
- Ajanta, Ranbaxy plan co-marketing 27 April 1999
